Literature DB >> 12188461

Women's perceptions of iron deficiency and anemia prevention and control in eight developing countries.

Rae Galloway1, Erin Dusch, Leslie Elder, Endang Achadi, Ruben Grajeda, Elena Hurtado, Mike Favin, Shubhada Kanani, Julie Marsaban, Nicolas Meda, K Mona Moore, Linda Morison, Neena Raina, Jolly Rajaratnam, Javier Rodriquez, Chitra Stephen.   

Abstract

The World Health Organization estimates that 58% of pregnant women in developing countries are anemic. In spite of the fact that most ministries of health in developing countries have policies to provide pregnant women with iron in a supplement form, maternal anemia prevalence has not declined significantly where large-scale programs have been evaluated. During the period 1991-98, the MotherCare Project and its partners conducted qualitative research to determine the major barriers and facilitators of iron supplementation programs for pregnant women in eight developing countries. Research results were used to develop pilot program strategies and interventions to reduce maternal anemia. Across-region results were examined and some differences were found but the similarity in the way women view anemia and react to taking iron tablets was more striking than differences encountered by region, country or ethnic group. While women frequently recognize symptoms of anemia, they do not know the clinical term for anemia. Half of women in all countries consider these symptoms to be a priority health concern that requires action and half do not. Those women who visit prenatal health services are often familiar with iron supplements, but commonly do not know why they are prescribed. Contrary to the belief that women stop taking iron tablets mainly due to negative side effects, only about one-third of women reported that they experienced negative side effects in these studies. During iron supplementation trials in five of the countries, only about one-tenth of the women stopped taking the tablets due to side effects. The major barrier to effective supplementation programs is inadequate supply. Additional barriers include inadequate counseling and distribution of iron tablets, difficult access and poor utilization of prenatal health care services, beliefs against consuming medications during pregnancy, and in most countries, fears that taking too much iron may cause too much blood or a big baby, making delivery more difficult. Facilitators include women's recognition of improved physical well being with the alleviation of symptoms of anemia, particularly fatigue, a better appetite, increased appreciation of benefits for the fetus, and subsequent increased demand for prevention and treatment of iron deficiency and anemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12188461     DOI: 10.1016/s0277-9536(01)00185-x

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  70 in total

1.  Blastocystis hominis as a contributing risk factor for development of iron deficiency anemia in pregnant women.

Authors:  Hala K El Deeb; Hesham Salah-Eldin; Seham Khodeer
Journal:  Parasitol Res       Date:  2011-12-14       Impact factor: 2.289

2.  Guidelines for iron supplementation in pregnancy: compliance among 431 parous Scandinavian women.

Authors:  H Nordeng; A Eskild; B-I Nesheim; I Aursnes; G Jacobsen
Journal:  Eur J Clin Pharmacol       Date:  2003-05-07       Impact factor: 2.953

3.  Patterns of compliance with prenatal iron supplementation among Peruvian women.

Authors:  Nelly Zavaleta; Laura E Caulfield; Alberto Figueroa; Ping Chen
Journal:  Matern Child Nutr       Date:  2012-05-16       Impact factor: 3.092

4.  Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India.

Authors:  P Mithra; B Unnikrishnan; T Rekha; K Nithin; K Mohan; V Kulkarni; R Holla; D Agarwal
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

5.  Predictors of anemia among pregnant women in Westmoreland, Jamaica.

Authors:  Alyson M Charles; Dianne Campbell-Stennett; Nelly Yatich; Pauline E Jolly
Journal:  Health Care Women Int       Date:  2010-07

6.  Relationship of maternal knowledge of anemia with maternal and child anemia and health-related behaviors targeted at anemia among families in Indonesia.

Authors:  Ellie S Souganidis; Kai Sun; Saskia de Pee; Klaus Kraemer; Jee-Hyun Rah; Regina Moench-Pfanner; Mayang Sari; Martin W Bloem; Richard D Semba
Journal:  Matern Child Health J       Date:  2012-12

7.  Linking traditional treatments of maternal anaemia to iron supplement use: an ethnographic case study from Pemba Island, Zanzibar.

Authors:  Sera L Young; Said M Ali
Journal:  Matern Child Nutr       Date:  2005-01       Impact factor: 3.092

8.  Utilization of folic acid and iron supplementation services by pregnant women attending an antenatal clinic at a regional referral hospital in Kenya.

Authors:  L Maina-Gathigi; J Omolo; P Wanzala; C Lindan; A Makokha
Journal:  Matern Child Health J       Date:  2013-09

9.  Study on Impact of Iron and Folic Acid on the Plasma Trace Minerals in Pregnant Anemic Women.

Authors:  Amit Kumar Mani Tiwari; Abbas Ali Mahdi; Sanjay Mishra
Journal:  Indian J Clin Biochem       Date:  2017-05-24

10.  Anemia prevalence and risk factors in pregnant women in an urban area of Pakistan.

Authors:  Naila Baig-Ansari; Salma Halai Badruddin; Rozina Karmaliani; Hillary Harris; Imtiaz Jehan; Omrana Pasha; Nancy Moss; Elizabeth M McClure; Robert L Goldenberg
Journal:  Food Nutr Bull       Date:  2008-06       Impact factor: 2.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.